JPMORGAN CHASE & CO - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 109 filers reported holding ANTARES PHARMA INC in Q4 2017. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$330,000
-23.4%
80,627
-33.2%
0.00%
Q4 2021$431,000
+27.1%
120,654
+29.6%
0.00%
Q3 2021$339,000
-68.9%
93,097
-62.7%
0.00%
Q2 2021$1,089,000
+56.2%
249,767
+47.1%
0.00%
Q1 2021$697,000
+48.6%
169,797
+44.3%
0.00%
Q4 2020$469,000
-77.5%
117,705
-84.7%
0.00%
Q3 2020$2,084,000
-9.2%
769,100
-7.9%
0.00%
Q2 2020$2,296,000
+84.9%
834,752
+58.6%
0.00%
Q1 2020$1,242,000
+370.5%
526,398
+837.5%
0.00%
Q4 2019$264,000
+49.2%
56,152
+5.9%
0.00%
Q3 2019$177,000
+25.5%
53,024
+19.4%
0.00%
Q2 2019$141,000
+31.8%
44,424
+26.1%
0.00%
Q1 2019$107,000
+7.0%
35,221
-4.5%
0.00%
Q4 2018$100,000
-96.8%
36,877
-96.1%
0.00%
-100.0%
Q3 2018$3,162,000
+176.2%
941,117
+112.2%
0.00%
Q2 2018$1,145,000
+16.0%
443,594
-1.1%
0.00%
Q1 2018$987,000
+600.0%
448,634
+533.6%
0.00%
Q4 2017$141,000
-65.6%
70,810
-44.4%
0.00%
Q2 2017$410,000
+327.1%
127,438
+275.9%
0.00%
Q1 2017$96,000
+540.0%
33,900
+277.0%
0.00%
Q3 2016$15,000
+200.0%
8,992
+73.3%
0.00%
Q2 2016$5,000
-99.7%
5,190
-99.4%
0.00%
Q2 2015$1,756,000
+1656.0%
844,100
+3323.1%
0.00%
Q3 2013$100,000
-42.2%
24,659
-40.7%
0.00%
Q2 2013$173,00041,5530.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders